195 related articles for article (PubMed ID: 7796129)
1. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice.
Suzuki T; Takamori K; Misawa M; Onodera K
Brain Res; 1995 Mar; 675(1-2):195-202. PubMed ID: 7796129
[TBL] [Abstract][Full Text] [Related]
2. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
Funada M; Suzuki T; Narita M; Misawa M; Nagase H
Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
[TBL] [Abstract][Full Text] [Related]
3. Endogenous histamine inhibits the development of morphine-induced conditioned place preference.
Gong YX; Lv M; Zhu YP; Zhu YY; Wei EQ; Shi H; Zeng QL; Chen Z
Acta Pharmacol Sin; 2007 Jan; 28(1):10-8. PubMed ID: 17184577
[TBL] [Abstract][Full Text] [Related]
4. Histaminergic neurons mediate restraint stress-induced activation of central 5-hydroxytryptaminergic neurons in the rat.
Fleckenstein AE; Lookingland KJ; Moore KE
Eur J Pharmacol; 1994 Oct; 264(2):163-7. PubMed ID: 7531644
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the histamine H1-antagonist-induced place preference in rats.
Suzuki T; Mori T; Tsuji M; Nomura M; Misawa M; Onodera K
Jpn J Pharmacol; 1999 Dec; 81(4):332-8. PubMed ID: 10669037
[TBL] [Abstract][Full Text] [Related]
6. Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
J Pharmacol Exp Ther; 1996 Oct; 279(1):177-85. PubMed ID: 8858991
[TBL] [Abstract][Full Text] [Related]
7. Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of alpha-fluoromethylhistidine and metoprine.
Yokoyama H; Onodera K; Maeyama K; Yanai K; Iinuma K; Tuomisto L; Watanabe T
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):40-5. PubMed ID: 1407004
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.
Hough LB; Nalwalk JW
Eur J Pharmacol; 1992 Apr; 215(1):69-74. PubMed ID: 1355443
[TBL] [Abstract][Full Text] [Related]
9. Central histaminergic involvement during stress in rats.
Ray A; Puri S; Chakravarty AK; Sen P
Indian J Exp Biol; 1992 Aug; 30(8):724-8. PubMed ID: 1360944
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine-induced rewarding effect in mice.
Aoki T; Narita M; Shibasaki M; Suzuki T
Eur J Neurosci; 2004 Sep; 20(6):1633-8. PubMed ID: 15355330
[TBL] [Abstract][Full Text] [Related]
11. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
Coruzzi G; Adami M; Pozzoli C; Poli E; Bertaccini G
Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
[TBL] [Abstract][Full Text] [Related]
12. Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats.
Ito C; Onodera K; Watanabe T; Sato M
Psychopharmacology (Berl); 1997 Apr; 130(4):362-7. PubMed ID: 9160852
[TBL] [Abstract][Full Text] [Related]
13. Zolantidine-induced attenuation of morphine antinociception in rhesus monkeys.
Hough LB; Nalwalk JW; Battles AH
Brain Res; 1990 Aug; 526(1):153-5. PubMed ID: 1981852
[TBL] [Abstract][Full Text] [Related]
14. Histaminergic H1 receptors mediate L-histidine-induced anxiety in elevated plus-maze test in mice.
Kumar KV; Krishna DR; Palit G
Behav Pharmacol; 2007 May; 18(3):213-7. PubMed ID: 17426485
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by kappa-opioid receptor activation in mice.
Narita M; Suzuki T; Funada M; Misawa M; Nagase H
Life Sci; 1993; 52(4):397-404. PubMed ID: 8380621
[TBL] [Abstract][Full Text] [Related]
16. Histaminergic receptors of medial septum and conditioned place preference: D1 dopamine receptor mechanism.
Zarrindast MR; Moghimi M; Rostami P; Rezayof A
Brain Res; 2006 Sep; 1109(1):108-16. PubMed ID: 16828718
[TBL] [Abstract][Full Text] [Related]
17. Histaminergic Neurotransmission as a Gateway for the Cognitive Effect of Oleoylethanolamide in Contextual Fear Conditioning.
Provensi G; Fabbri R; Munari L; Costa A; Baldi E; Bucherelli C; Blandina P; Passani MB
Int J Neuropsychopharmacol; 2017 May; 20(5):392-399. PubMed ID: 28339575
[TBL] [Abstract][Full Text] [Related]
18. Effects of zolantidine a brain-penetrating H2-receptor antagonist, on naloxone-sensitive and naloxone-resistant analgesia.
Gogas KR; Hough LB
Neuropharmacology; 1988 Apr; 27(4):357-62. PubMed ID: 2901671
[TBL] [Abstract][Full Text] [Related]
19. Interactions between neuronal histamine and halothane anesthesia in rats.
Mammoto T; Yamamoto Y; Kagawa K; Hayashi Y; Mashimo T; Yoshiya I; Yamatodani A
J Neurochem; 1997 Jul; 69(1):406-11. PubMed ID: 9202335
[TBL] [Abstract][Full Text] [Related]
20. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
Narita M; Kishimoto Y; Ise Y; Yajima Y; Misawa K; Suzuki T
Neuropsychopharmacology; 2005 Jan; 30(1):111-8. PubMed ID: 15257306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
